We are live on ! Find out more
CRL icon

Charles River Laboratories

252 hedge funds and large institutions have $3.49B invested in Charles River Laboratories in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 77 increasing their positions, 109 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more call options, than puts

Call options by funds: $999K | Put options by funds: $464K

26% more capital invested

Capital invested by funds: $2.77B → $3.49B (+$714M)

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

1% less funds holding

Funds holding: 255252 (-3)

1.43% less ownership

Funds ownership: 100.05%98.62% (-1.4%)

29% less repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 109

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
252
Holders Change
-3
Holders Change %
-1.18%
% of All Funds
6.72%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
26
Increased
77
Reduced
109
Closed
24
Calls
$999K
Puts
$464K
Net Calls
+$535K
Net Calls Change
-$5.16M
Name Holding Trade Value Shares
Change
Change in
Stake
BIM
51
BlackRock Investment Management
Delaware
$11.7M +$176K +2,814 +2%
ACM
52
Apex Capital Management
Ohio
$11.5M +$2.84M +45,373 +33%
QI
53
QS Investors
New York
$11.4M +$11.3M +179,797 New
PAM
54
Panagora Asset Management
Massachusetts
$11.4M -$32.9K -525 -0.3%
KCM
55
Kornitzer Capital Management
Kansas
$11.3M -$25.1K -400 -0.2%
UBS AM
56
UBS AM
Illinois
$10.5M -$125K -2,000 -1%
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$10.4M -$5.97M -95,309 -37%
HP
58
HealthInvest Partners
Sweden
$10.3M
BlackRock
59
BlackRock
New York
$9.87M -$7.53M -120,094 -44%
WA
60
Westport Advisers
Connecticut
$9.86M
Asset Management One
61
Asset Management One
Japan
$9.77M
ACM
62
American Capital Management
New York
$9.59M +$37.6K +600 +0.4%
EBIM
63
Eagle Boston Investment Management
Massachusetts
$9.58M -$2.94M -46,968 -24%
TCIM
64
TIAA CREF Investment Management
New York
$9.49M +$3.04M +48,483 +48%
Charles Schwab
65
Charles Schwab
California
$8.34M -$1.72M -27,419 -17%
Principal Financial Group
66
Principal Financial Group
Iowa
$8.3M -$4.15M -66,199 -34%
VanEck Associates
67
VanEck Associates
New York
$7.89M +$281K +4,483 +4%
DVM
68
Dreman Value Management
Florida
$7.41M +$321K +5,124 +5%
MPAM
69
Monarch Partners Asset Management
Massachusetts
$7.11M -$3.15M -50,321 -31%
American Century Companies
70
American Century Companies
Missouri
$7M -$1.02M -16,231 -13%
CCP
71
Clarkston Capital Partners
Michigan
$6.92M +$127K +2,025 +2%
D.E. Shaw & Co
72
D.E. Shaw & Co
New York
$6.69M -$9.04M -144,227 -58%
JP Morgan Chase
73
JP Morgan Chase
New York
$6.66M +$454K +7,245 +7%
Susquehanna International Group
74
Susquehanna International Group
Pennsylvania
$6.61M +$1.84M +29,295 +39%
PPA
75
Parametric Portfolio Associates
Washington
$6.49M +$239K +3,813 +4%

CRL Hedge Fund Activity: Q4 2014 in Review

252 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2014, worth a combined $3.49B — up 26% from $2.77B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CRL positions and 24 closed out — a net gain of 2 holders — while 77 added to existing stakes and 109 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $77.7M. The largest seller was Wellington Management Group, cutting an estimated $16.6M.

  • 252 institutional investors held Charles River Laboratories (CRL) as of Q4 2014, down from 255 in Q3 2014.
  • Funds reported $3.49B of Charles River Laboratories stock for Q4 2014, up 26% quarter-over-quarter.
  • 26 funds opened new Charles River Laboratories positions in Q4 2014 and 24 closed out, a net change of +2 holders.
  • The largest Charles River Laboratories buyer in Q4 2014 was First Trust Advisors, an estimated $77.7M added.
  • The largest Charles River Laboratories seller in Q4 2014 was Wellington Management Group, an estimated $16.6M sold.

Based on aggregated 13F filings for Q4 2014.